Comparison of Cardiopulmonary Exercise Capacity in Patients with Atrial Septal Defect Treated with Minimally Invasive Cardiac Surgery or Transcatheter Closure

Aim. The main aim of our study was to compare the results of transcatheter atrial septal defect (ASD) closure versus minimally invasive cardiac surgery (MICS) focusing on cardiopulmonary exercise capacity and echocardiographic findings preoperatively and 1 month after defect closure.

Material and methods. 54 patients with ASD and finally 43 patients who were followed up were included in the study. 21 patients were in MICS (robotic or endoscopic approach) and 22 patients were in transcatheter closure arm. All patients investigated in detail by transesophageal echocardiography and underwent cardiopulmonary exercise test (CPET). At the end of first month, CPET and transthorasic echocardiography were reperformed.

Results. There was significant improvement of physical capacity after 1 month following the transcatheter closure procedure documented by exercise time and VO 2 max. Tricuspid annular plane systolic excursion (TAPSE) and tricuspid lateral annular systolic velocity (Tri S) were not changed. In surgery group right heart diameters declined significantly; but VO 2 max, TAPSE and Tri S significantly decreased.

Conclusion. Cardiopulmonary exercise function is increased in transcatheter closure group 1 month after closure and contrary not in MICS group. This may be caused by long recovery time of the right ventricle after surgery. Device closure of ASD is preferable to surgical closure if the anatomy is suitable. However, MICS for ASD closure is safe, with short recovery period and less scarring.

1. Murphy JG, Gersh BJ, McGoon MD, et al. Long-term outcome after surgical repair of isolated atrial septal defect: follow-up at 27 to 32 years. N Engl J Med. 1990;323(24):1645-50. doi:10.1056/NEJM199012133232401.

2. Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). J Am Coll Cardiol. 2008;52:e143-263. doi:10.1016/j.jacc.2008.10.001.

3. Cuypers JA, Opić P, Menting ME, et al. The unnatural history of an atrial septal defect: longitudinal 35 year follow up after surgical closure at young age. Heart. 2013;99(18):1346-52. doi:10.1136/heartjnl-2013-304225.

4. Pedra CA, Pedra SR, Esteves CA, et al. Trancatheter closure of secundum atrial septal defects with complex anatomy. J Invas Cardiol. 2004;16:117-22.

5. Du ZD, Hijazi ZM, Kleinman ChS, et al. Amplatzer Investigators. Comparison Between Transcatheter and Surgical Closure of Secundum Atrial Septal Defect in Children and Adults. Results of Multicenter Nonrandomized Trial. J Am Coll Cardiol. 2002;39:1836-44. doi:10.1016/s0735-1097(02)01862-4.

6. Berger F, Vogel M, Alexi-Meskishvili V, et al. Comparison of Results and Complications of Surgical and Amplatzer Device Closure of Atrial Septal Defect. J Thorac Cardiovasc Surg. 1999;118:674-80. discussion 678-80. doi:10.1016/S0022-5223(99)70013-9.

7. Rosas M, Zabal C, Garcia-Montes J, et al. Transcatheter versus surgical closure of secundum atrial septal defect in adults: impact of age at intervention. A concurrent matched comparative study. Congenit Heart Dis. 2007;2:148-55. doi:10.1111/j.17470803.2007.00091.x.

8. Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/ American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73:e81-e192. doi:10.1016/j.jacc.2018.08.1029.

9. Tran D. Cardiopulmonary Exercise Testing. Methods Mol Biol. 2018;1735:285-95. doi:10.1007/978-1-4939-7614-0_18.

10. Yang MC, Wu JR. Recent review of transcatheter closure of atrial septal defect. Kaohsiung J Med Sci. 2018;34(7):363-9. doi:10.1016/j.kjms.2018.05.001.

11. Attie F, Rosas M, Granados N, et al. Surgical treatment for secundum atrial septal defects in patients >40 years old. A randomized clinical trial. J Am Coll Cardiol. 2001;38:2035-42. doi:10.1016/s0735-1097(01)01635-7.

12. Komar M, Przewlocki T, Olszowska M, et al. The benefit of atrial septal defect closure in elderly patients. Clin Interv Aging . 2014;9:1101-7. doi:10.2147/CIA.S62313.

13. Kobayashi A, Kunii H, Yokokawa T, et al. Safety and effectiveness of transcatheter closure of atrial septal defects: Initial results in Fukushima Prefecture. Fukushima J. Med. Sci. 2018;64(3):151-6. doi:10.5387/fms.2018-13.

14. Mylonas KS, Ziogas IA, Evangeliou A, et al. Minimally Invasive Surgery vs Device Closure for Atrial Septal Defects: A Systematic Review and Meta-analysis. Pediatr Cardiol. 2020;10.1007/s00246-020-02341-y. doi:10.1007/s00246-020-02341-y. [online ahead of print]

15. Prochownik P, Przewłock T, Podolec P, et al. Improvement of physical capacity in patients undergoing transcatheter closure of atrial septal defects. Adv Interv Cardiol. 2018;14,1(51):90-4. doi:10.5114/aic.2018.74360.

16. Helber U, Bauman R, Sebold H, et al. Atrial septal defect in adults: cardiopulmonary exercise capacity before and 4 months and 10 years after defect closure. J Am Coll Cardiol. 1997;29:1345-50. doi:10.1016/s0735-1097(97)00058-2.

17. Kobayashi Y, Nakanishi N, Kosakai Y. Pre- and postoperative exercise capacity associated with hemodynamics in adult patients with atrial septal defect: A retrospective study. Eur J Cardiothorac Surg . 1997;11(6):1062-6. doi:10.1016/s1010-7940(96)01131-1.

18. Dhillon R, Josen M, Henein M, et al. Transcatheter closure of atrial septal defect preserves right ventricular function. Heart. 2002;87(5):461-5. doi:10.1136/heart.87.5.461.

19. Du ZD, Cao QL, Koenig P, et al. Speed of normalization of right ventricular volume overload after transcatheter closure of atrial septal defect in children and adults. Am J Cardiol. 2001;88(12):1450-3, A9. doi:10.1016/s0002-9149(01)02135-x.

20. Stephensen SS, Ostenfeld E, Kutty S, et al. Transcatheter closure of atrial septal defect in adults: time-course of atrial and ventricular remodeling and effects on exercise capacity. Int J Cardiovasc Imaging. 2019;35(11):2077-84. doi:10.1007/s10554-019-01647-0.

21. Santos M, Systrom D, Epstein SE, et al. Impaired exercise capacity following atrial septal defect closure: an invasive study of the right heart and pulmonary circulation. Pulm Circ 2014;4(4):630-7. doi:10.1086/678509.

22. Lange SA, Braun MU, Schoen SP, et al. Latent pulmonary hypertension in atrial septal defect: Dynamic stress echocardiography reveals unapparent pulmonary hypertension and confirms rapid normalization after ASD closure. Neth Heart J. 2013;21:333-43. doi:10.1007/s12471-013-0425-8.

23. Takaya Y, Taniguchi M, Akagi T, et al. Long-term effects of transcatheter closure of atrial septal defect on cardiac remodeling and exercise capacity in patients older than 40 years with a reduction in cardiopulmonary function. J Interv Cardiol. 2013; 26:195-9. doi:10.1111/joic.12002.

24. Suchon E, Pieculewicz M, Tracz W, et al. Transcatheter closure as an alternative and equivalent method to the surgical treatment of atrial septal defect in adults: comparison of early and late results. Med Sci Monit. 2009;15:CR612-7.